Displaying all 28 episodes
In this episode, we are talking to Chris Rehse, founder and and CEO of Neotiv. Founded in 2017, neotiv has developed a digital assistant to monitor and aid the memory of patients with Dementia and Alzheimer's and focuses on improving the early detection of these conditions to facilitate efficacy monitoring, new therapies, and early intervention and prevention of brain health. Relevant for medical underwriting and post-purchase prevention and intervention measures, neotiv's medical platform presents cognitive tests to track cognitive changes in memory and visual information over time. The company also focuses on research, diagnostics and drug development for these conditions.
What if AI and Big Data meet foresight? Praedicat in partnership with SCOR, offers a forward looking emerging risk model. Through this podcast we are going to understand how this tool works and how it can help our Casualty team to develop their relationship with the clients. Why is there a lag in the casualty catastrophe models compared to the property market? What are the main advantages from a casualty underwriting perspective but also from a claim perspective? The time savings and risk reduction enabled by Praedicat also make it possible to start new conversations and projects with clients. Maura Haynes, a US citizen and Argentinian, joined SCOR in 2016 and was promoted to US GL Team Leader in 2019. She has over 20 years of experience in the insurance and reinsurance industry. Prior to SCOR, Maura worked at Swiss Re in various underwriting capacities. Maura graduated from Central Michigan University with a bachelor’s degree in Business Administration. She has also achieved an MBA from Northwood University. Steven Strauss has been appointed as US Deputy Team Leader for Casualty. Before 2014, Steven was the Vice President of Business Development at Berkley Program Specialists. He was responsible for the generation of new business and the continuing development of existing relationships with a growing portfolio of Program Administrators. Steven is gaduated from Lake Forest College, in Illinois. Emale Laurant is Vice President, Accumulation Team Lead for the Global Casualty lines related to the processes ranging from supporting the Global and Legal Entity accumulations of risks. He has been working at SCOR for 5 years, before he was Risk Actuary at AIG and XL Group. Emale is graduated from Trinity College-Hartford, Connectitut, with a BS Degree option Mathematics and Chemistry.
Global fertility has been declining at a fast pace. From 1990 to 2019, the fertility rate fell from 3.2 to 2.5 live births per woman. We are talking to Pascal Koenig, co-founder and board member of Ava about tackling infertility with science. Ava is clinically proven to identify both the opening and closing of the fertile window, letting you know your five best days to try for a baby. In a world where fertility is falling due to lower childhood mortality rates, access to birth control, and focus on career development for women and men, one in seven couples may have difficulties conceiving. With medical treatments being considerably expensive, Swiss startup Ava has created a wearable to identify a woman’s fertile window based on 3 million biomarkers.
Did you know that in Latin America, for every thousand individuals, there are only two physicians? Imagine you are at home, feeling terribly sick but having no access to medical care. Colombian startup 1DOC3 is tackling this exact situation as the largest telemedicine provider in Latin America. There is no more Doctor Google. Today we are talking to Javier Cardona, co-founder, and CEO of 1DOC3. How does it work? 1DOC3 is connecting doctors with people who have health related questions with their AI-driven symptom checker and chat. With over 1.5 million users and 300.000 consults every month, 1DOC3's digital health platform providers individualised medical information to Spanish speakers in countries like Colombia and Mexico.
ESG, CSR, two terms that we hear more and more in our personal and professional lives. What do they stand for and why are they so important today in business strategies? Paul Nunn, Senior Advisor in charge of ESG strategy for SCOR P&C, introduces and differentiates these themes, with examples and use cases. He then explains the various innovations and trends that we will face in the near future from sustainable and social aspects, and with a focus on the (re)insurance industry. Green hydrogen, wind farms, energy efficiency, carbon capture, etc. If you are not yet comfortable with these topics, find out what they could bring to your business in this 15min podcast. Before his current position, Paul was responsible for pricing catastrophe risk on inwards business, and accumulation of catastrophe loss potential for natural hazard perils globally. Alongside his role at SCOR P&C, Paul is a director of the non-profit Oasis Loss Modelling Framework company, an open source platform for developing, deploying and executing catastrophe models. He is also actively participating in the Insurance Development Forum working group on Risk Modelling & Mapping, which seeks to improve global understanding and quantification of disaster risk, particularly in developing countries.
With a population of 1.4 billion people, China has seen half a century of rapid growth as the second largest economy in the world. Despite 95% of the population has basic health insurance coverage, many are turning to private health insurance, a market estimated to exceed spending of one trillion dollars in 2020. Today we are talking to Sebastien Gaudin, co-founder, and CEO of The Carevoice, a tech-driven startup which has created a healthcare operating system which connects insurers, pharmacies, physicians, hospitals and care providers, and the pharma industry to care and cure patients. As you will hear, Sebastian and I faced the challenges of working from home, so the quality of the call reflects this. We hope you enjoy the episode.
Will Thorne, Will Bird and Dana Cullen of P&C Ventures host this week’s SCOR Innovation Podcast, discussing the team’s origins, investment theses, activities and the launch of their new three year strategy: Ventures 2.0. Will Thorne is the Head of P&C Ventures. Will has a background in both (re)insurance underwriting and start-ups. He is a frequent advisor & angel investor in his personal capacity and was the founding chair of the UK Insurtech Board. Will Bird is an Associate based in Chicago. Will focuses on investment & partnership opportunities in the Americas. His previous experience includes corporate venture capital and strategy at a leading U.S. personal lines insurer. Dana Cullen is an Innovation Associate based in London. Dana has a background in actuarial pricing and epidemiology, having previously worked for SCOR Global Life, and focuses on the development and execution of Insurtech MGA/carrier partnerships.
The mean cost of developing a new drug has been the subject of debate for many years. A recent study conducted by the London School of Economics estimates a range from 314 million USD to 2.8 billion. And despite the costs varying across different disease areas, it is still a pricey and very lengthy process. In today's episode, we are talking to Tamás Görbe, co-founder and CSO of Menten.AI. Known as one of the most notorious startups using quantum computing in drug research and development. Backed by Y Combinator in 2020, the American startup accelerator which launched Airbnb or Dropbox. The startup uses machine learning and quantum computing to create the next generation of protein-based drugs and enzymes focused on rare diseases, neurological disorders, or viruses.
How is the cloud changing the face of healthcare? Launched in 2020, Google Cloud’s healthcare solutions tackle some of the biggest pain points such as interoperability and security to support data-driven decision-making and ultimately, deliver better care. In this podcast episode, we are talking to Aashima Gupta, director of Global healthcare solutions at Google Cloud. In her current position as director of Global Healthcare solutions, she is accountable for driving healthcare strategy and solutions using AI, cloud services, APIs and mobile solutions. During her career, Aashima has focused on transformational healthcare in complex enterprise environments.
2020 has been a challenging year for cyber (re)insurance. Rise in ransomware claims and swelling loss ratios caused (re)insurers to review their cyber appetite, triggering correction in rates and reduction in available capacity. What have been the most notable developments in 2020 and where are we headed in 2021? To find out, listen to our 3rd Property & Casualty episode, where Bill Kaplan, Global Casualty Chief Underwriting Officer for Cyber Liability and Margaret Rose, Head of Financial Lines Americas for Specialty Insurance, share their views on insurance and reinsurance cyber markets in the US. Bill joined SCOR six years ago as the Professional Liability Team Leader. Prior to this, he spent 3 years at Protective Re as Director of Professional Liability Treaty. Bill has an MBA in Finance from the Loyola University of Chicago, and is still based in Chicago. Margaret is based in NYC. She began her career with SCOR as an underwriter for Professional Liability and Cyber in 2017. Previously, she worked as an underwriter for Axis and Tokyo Marine. She has also an MBA in Finance, from the New York University.
Diabetes is rising worldwide. Today, over 425 million people have diabetes and projections predict that by 2045, there will be 700 million people with this condition. And despite diabetes can be treated, prevented or delayed with diet, physicial activity, medication and regular screening, every year more than 1.6 million deaths are attributed to the condition. Today we are talking to Jeff Dachis, founder, chairman and CEO of One Drop, a company taking a data approach to help people with diabetes to manage and improve their blood-sugar levels through actionable insights. One Drop combines clinical science, advanced AI, and data points to give those with diabetes, high cholesterol, prediabetes, and high blood pressure the opportunity to make changes that last.
Today we are talking to Sibylle Fischer, Director of Strategic Venturing and Startup Scouting of Baloise. The Swiss insurer, which is known in the market for its insurance and banking products, also chasing unicorns in the insurtech space. Despite having a tradition of 150 years, the insurer has worked intensely on its digital agenda for the past years, with activities ranging to traditional venture capital investment to venture building, ecosystem development, and partnerships with startups beyond the life and health scope. Let’s explore their experience in the past years and the direction ahead with Sibylle Fischer.
Nick Nudo, CUO for North America Property & Casualty Reinsurance @ SCOR, recaps the 2021 January renewals to help you get ready for what's next.
In the 1st ever P&C episode John Jenkins, Head of the Americas Property & Casualty @SCOR, looks back on the market trends that played a role in US reinsurance in 2020.
As we share our last episode of 2020 and prepare for an exciting new year, we are talking to Bernd Müller, creator of this podcast and head of SCOR Life and Health ventures about the podcast, his favorite episodes, and the biggest lessons learned this year. After this, we tackle mental health. According to the World Health Organization, depression is the leading cause of disability worldwide. On average, mental disorders reduce life expectancy by 10 to 25 years in patients with severe mental disorders, as most of these deaths are due to chronic physical medical conditions including cardiovascular problems, diabetes, or infection diseases. Today we are talking to Paul Feldhausen from Holmusk, a tech driven Singapore-based startup focused on reversing chronic disease and behavioral health issues through EHR, data analytics and digital therapeutics.
During 2020, we have gone through an immense amount of change, uncertainty, and disruption. The current pandemic has shown us the accelerated pace of scientific discovery; from vaccines to long term health consequences after Covid-19, every day there are new revelations impacting directly and indirectly our industry. In this episode we talked to Dipanwita Das, co-founder and CEO of Sorcero, a company ususing cognitive technology to interpret language and consider the meaning and context of information from its origin to its cross-industry applications. Instead of fully automating processes and workflows, Sorcero uses AI to build knowledge based on their clients' knowledge systems and ontologies, and to integrate new information into these existing systems.
Have you ever wondered if the physician you are meeting is the most qualified? What about having the right experience precisely for the condition you have, if the previous patients recovered successfully, or had a positive experience? Choosing a care doctor is one of the most important decisions we make when it comes to our health. Our complex healthcare systems evolve. But who is helping patients and policyholders to navigate them? We are talking to Grace Park, co-founder and president of DocDoc, who inspired by her own personal story created the largest doctor discovery company in Asia. DocDoc empowers patients to make the best healthcare decisions through data, with transparency and fairness. You can subcribe to the SCOR Life and Health Innovation podcast on Apple Podcast, Spotify, or wherever you listen to our conversations to be the first one to list to our new episodes. Have a speaker in mind or want to share your insights with us? Send us a message to firstname.lastname@example.org wth your thoughts.
End of October 2020 marked a milestone for the Brazilian startup ecosystem: Sami became the most funded Series A startup after raising $15.5 million USD from international investors including Valor, Redpoint, and Monashees. In the latest episode of the SCOR Life and Health Innovation Podcast, we are talking to Luiz Guilherme Berardo, co-founder and CEO of Sami. The start-up aims to redesign the health care industry in Brazil with technology by driving payments through patient outcome. In Sami’s model, data exchange allows us to realign care incentives and pay providers based on the health of patients and not on a fee-for-service. With over 200 thousand users, Sami is challenging their status quo and putting patients in the center.
Around 75% of Americans have trouble taking their medication as directed according to the New England Health Care Institute. Today we’re talking to Matthew Loper, co-founder and CEO of Wellth, an American startup based in Los Angeles, which is using behavioural economics to inspire positive behaviour change for patients with chronic health conditions. In their app, Wellth uses financial incentives to overcome present bias and motivate patients to adhere to their daily care plans and improve their health. The impact on the insurance industry? Saving health plans and providers billions on avoidable costs in high risk populations, including those in Medicare and Medicaid.
After more than 20 years in the innovation ecosystem, Georg Schwegler, CEO of Transamerica Ventures, has been in the venture capital industry in telecommunications, R&D, marketing and innovation research. How is this experience relevant to investing in startups and what’s the strategy behind Transamerica ventures?
Tel Aviv is a hotspot for innovation and more than ever also for health. We had an exciting conversation with Gil Arazi, co-founder and partner of FinTLV. Investor and connector, Gil is has over 20 years of experience in the insurance industry and is behind deals like the latest $150M investment round of insurtech, Hippo.
In this episode, we’re talking to Fabian Nadler, head of digital insurance and insurtech at Bitkom, Germany’s largest digital association bringing together SMEs, startups, and virtually all global players. We explore the German startup ecosystem, how cross-industry cooperations are enriching customer journeys in established worlds, and how data can be a turning point for privacy-driven German customers.
In this episode, we talk to George Eleftheriou, co-founder and CEO of Sentio Solutions. Sentio partners with SCOR in Germany to offers clients of disability insurance portfolios to build better and lasting emotional health. Based in San Francisco, the company developed its own propritary sensor to quantify emotional states and combine it with evidence-based techniques to deliver mental health support 24/7.
We take care of our bodies by going to the gym, we tweak and carefully monitor out diets, we go to the doctor for annual check-ups and take medication when to prevent disease or when we're sick to recover promptly. However, it seems like the same approach we have for our bodies is not consistent with the approach we have with our minds or our brain. Today we're talking to Dr. John Harrison, associate professor at the Alzheimer's Center at the VUmc in the Netherlands. John has over 20 years' experience understanding Alzheimer's disease and other neurodegeneative conditions and has worked with pharmaceutical and biotech companies with the selection and successful integration of cognitive testing into drug development programs. An Alzheimer's disease advocate, he has over 60 books and scientific articles on the topic, including depression, schizophrenia, and Parkinson’s disease.
Did you know there are over 3.100 early-stage European startups focused on disrupting the insurance industry? How do we know this? We’re talking to Florian Graillot, co-founding partner of Astorya VC, an early-stage venture capital fund in Paris focused on insurtechs. Florian Graillot is known as one of the leading voices in the insurance innovation space. With a decade of experience in the insurance industry, we’re exploring the startups ecosystem in Europe and how to find the most relevant startups before they are known in their own markets.
From videogame developer to pediatric orthopedic surgeon to founder, we're talking to Justin Barad, founder and CEO of Osso VR. This American startup is transforming surgical training and assessment with their virtual reality medical platform. Despite we're living on a rapidly evolving healthcare ecosystem, traditional training and education modalities in medicine have struggled to keep up with new technologies to deliver higher value of treatment, prevention, and intervention. Let's explore how Osso VR is improving patient safety and democratizing access to modern surgical techniques.
Investor, corporate innovator, exited founder, consultant, and runner. Innovators can wear many hats throughout their career. As proof, today we're talking to Eugene Borukhovich. Serial intra and entrepreneur, executive, venture builder, and board advisor with a focus in digital health and many years of experience in both the corporate and entrepreneurial world. Eugene is a chairman and founding board member of YourCoach Health, a startup focused on empowering health coaching with an enriched approached on individuals and groups.
What if AI could say you don't need a risky heart surgery like the doctor prescribed? Or what if it could help identifying cancer in an X-ray with higher accuracy at an earlier stage? Sounds like the future, but American startup Arterys is doing this already in 28 countries. Want to know how? In our SCOR Life and Health Innovation Podcast we're exploring medical imaging, cancer, Covid-19, and how doctors can get some little help from their AI friend to improve patient journey and get the best treatments and diagnosis faster than ever.